Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Ginkgo Bioworks Holdings, Inc.DNA · Entity 5530 | 10% owner | July 28, 2026 | July 30, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Ginkgo Bioworks Holdings, Inc.
Report date July 28, 2026 · Filed July 30, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 35,736 |
Reported balance
After 2026-07-28 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-07-28 · Grant · Acquired 35,736 · Balance 35,736 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2: The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 117,135 |
Reported balance
After 2026-07-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-28 · Grant · Acquired 117,135 · Balance 117,135 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3: The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | IndirectBy Spouse | 39,038 |
Reported balance
After 2026-07-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-07-28 · Grant · Acquired 39,038 · Balance 39,038 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F2: The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | IndirectBy Spouse | 127,423 |
Reported balance
After 2026-07-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-07-28 · Grant · Acquired 127,423 · Balance 127,423 F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock. F3: The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Class A Common Stock.
F2: The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest as follows: 75% on October 16, 2026 and 25% on January 21, 2027.
F3: The RSUs were approved by the Compensation Committee of the Board of Directors on July 28, 2026 and shall vest in equal quarterly installments over the next 12 quarters, with the first vesting to occur on October 16, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2022 Filed Dec 6, 2022 02:14 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 100,429 | $1.97 | $198,045.99 |
DisclosureSEC source: 0000899243-22-037731 · doc4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,018,755 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 30, 2022 Filed Dec 1, 2022 22:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 102,676 | $1.79 | $184,098.07 |
DisclosureSEC source: 0000899243-22-037296 · doc4.xml · nonDerivative · entry 4 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 20,119,183 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 30, 2022 Filed Dec 1, 2022 22:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 102,676 | $1.79 | $184,098.07 |
DisclosureSEC source: 0000899243-22-037296 · doc4.xml · nonDerivative · entry 3 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,119,184 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 29, 2022 Filed Dec 1, 2022 22:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 96,433 | $1.90 | $183,126.27 |
DisclosureSEC source: 0000899243-22-037296 · doc4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 20,221,859 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 29, 2022 Filed Dec 1, 2022 22:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 96,434 | $1.90 | $183,128.17 |
DisclosureSEC source: 0000899243-22-037296 · doc4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,221,860 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 23, 2022 Filed Nov 25, 2022 22:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 99,798 | $1.99 | $198,997.21 |
DisclosureSEC source: 0000899243-22-037049 · doc4.xml · nonDerivative · entry 4 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 20,318,292 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 23, 2022 Filed Nov 25, 2022 22:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 99,797 | $1.99 | $198,995.22 |
DisclosureSEC source: 0000899243-22-037049 · doc4.xml · nonDerivative · entry 3 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,318,294 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 22, 2022 Filed Nov 25, 2022 22:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 101,813 | $2.04 | $208,003.96 |
DisclosureSEC source: 0000899243-22-037049 · doc4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 20,418,090 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 22, 2022 Filed Nov 25, 2022 22:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 101,813 | $2.04 | $208,003.96 |
DisclosureSEC source: 0000899243-22-037049 · doc4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,418,091 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 103,764 | $2.10 | $217,904.40 |
DisclosureSEC source: 0000899243-22-036787 · doc4.xml · nonDerivative · entry 4 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 20,519,903 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 21, 2022 Filed Nov 22, 2022 22:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 103,765 | $2.10 | $217,906.50 |
DisclosureSEC source: 0000899243-22-036787 · doc4.xml · nonDerivative · entry 3 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,519,904 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 18, 2022 Filed Nov 22, 2022 22:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 98,562 | $2.17 | $213,879.54 |
DisclosureSEC source: 0000899243-22-036787 · doc4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 20,623,667 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 18, 2022 Filed Nov 22, 2022 22:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 98,562 | $2.17 | $213,879.54 |
DisclosureSEC source: 0000899243-22-036787 · doc4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,623,669 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 17, 2022 Filed Nov 19, 2022 02:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 221,401 | $2.09 | $461,621.09 |
DisclosureSEC source: 0000899243-22-036456 · doc4.xml · nonDerivative · entry 4 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 20,722,229 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 17, 2022 Filed Nov 19, 2022 02:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 221,402 | $2.09 | $461,623.17 |
DisclosureSEC source: 0000899243-22-036456 · doc4.xml · nonDerivative · entry 3 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,722,231 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 16, 2022 Filed Nov 19, 2022 02:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 219,089 | $2.43 | $531,290.83 |
DisclosureSEC source: 0000899243-22-036456 · doc4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 20,943,630 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 16, 2022 Filed Nov 19, 2022 02:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 219,088 | $2.43 | $531,288.40 |
DisclosureSEC source: 0000899243-22-036456 · doc4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,943,633 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 22:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 212,443 | $2.51 | $533,231.93 |
DisclosureSEC source: 0000899243-22-036023 · doc4.xml · nonDerivative · entry 4 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 21,162,719 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 15, 2022 Filed Nov 16, 2022 22:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 212,443 | $2.51 | $533,231.93 |
DisclosureSEC source: 0000899243-22-036023 · doc4.xml · nonDerivative · entry 3 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,162,721 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 14, 2022 Filed Nov 16, 2022 22:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 208,633 | $2.72 | $567,064.49 |
DisclosureSEC source: 0000899243-22-036023 · doc4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 21,375,162 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 14, 2022 Filed Nov 16, 2022 22:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 208,632 | $2.72 | $567,061.78 |
DisclosureSEC source: 0000899243-22-036023 · doc4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,375,164 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 02:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 197,964 | $2.65 | $525,396.46 |
DisclosureSEC source: 0000899243-22-035786 · doc4.xml · nonDerivative · entry 4 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 21,583,795 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 11, 2022 Filed Nov 15, 2022 02:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 197,964 | $2.65 | $525,396.46 |
DisclosureSEC source: 0000899243-22-035786 · doc4.xml · nonDerivative · entry 3 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,583,796 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 10, 2022 Filed Nov 15, 2022 02:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 186,028 | $2.46 | $457,628.88 |
DisclosureSEC source: 0000899243-22-035786 · doc4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 21,781,759 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 10, 2022 Filed Nov 15, 2022 02:00 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 186,028 | $2.46 | $457,628.88 |
DisclosureSEC source: 0000899243-22-035786 · doc4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,781,760 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 22:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 207,960 | $2.43 | $505,550.76 |
DisclosureSEC source: 0000899243-22-035554 · doc4.xml · nonDerivative · entry 4 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 21,967,787 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 09, 2022 Filed Nov 10, 2022 22:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 207,959 | $2.43 | $505,548.33 |
DisclosureSEC source: 0000899243-22-035554 · doc4.xml · nonDerivative · entry 3 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,967,788 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 22:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 193,616 | $2.46 | $475,520.90 |
DisclosureSEC source: 0000899243-22-035554 · doc4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 22,175,747 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 08, 2022 Filed Nov 10, 2022 22:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 193,616 | $2.46 | $475,520.90 |
DisclosureSEC source: 0000899243-22-035554 · doc4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,175,747 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 22:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 205,809 | $2.42 | $497,440.35 |
DisclosureSEC source: 0000899243-22-035374 · doc4.xml · nonDerivative · entry 4 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 22,369,363 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 07, 2022 Filed Nov 8, 2022 22:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 205,809 | $2.42 | $497,440.35 |
DisclosureSEC source: 0000899243-22-035374 · doc4.xml · nonDerivative · entry 3 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,369,363 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 04, 2022 Filed Nov 8, 2022 22:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 204,906 | $2.51 | $513,494.44 |
DisclosureSEC source: 0000899243-22-035374 · doc4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 22,575,172 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 04, 2022 Filed Nov 8, 2022 22:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 204,906 | $2.51 | $513,494.44 |
DisclosureSEC source: 0000899243-22-035374 · doc4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,575,172 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 21:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 196,307 | $2.77 | $543,377.78 |
DisclosureSEC source: 0000899243-22-034951 · doc4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 22,780,078 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| November 01, 2022 Filed Nov 3, 2022 21:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 196,308 | $2.77 | $543,380.54 |
DisclosureSEC source: 0000899243-22-034951 · doc4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,780,078 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| October 31, 2022 Filed Nov 1, 2022 21:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 197,899 | $2.71 | $535,316.80 |
DisclosureSEC source: 0000899243-22-034705 · doc4.xml · nonDerivative · entry 4 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 22,976,385 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| October 31, 2022 Filed Nov 1, 2022 21:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 197,899 | $2.71 | $535,316.80 |
DisclosureSEC source: 0000899243-22-034705 · doc4.xml · nonDerivative · entry 3 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,976,386 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 21:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 199,307 | $2.63 | $523,380.18 |
DisclosureSEC source: 0000899243-22-034705 · doc4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 23,174,284 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| October 28, 2022 Filed Nov 1, 2022 21:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 199,307 | $2.63 | $523,380.18 |
DisclosureSEC source: 0000899243-22-034705 · doc4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,174,285 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| October 27, 2022 Filed Oct 28, 2022 22:49 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 204,477 | $2.71 | $553,314.76 |
DisclosureSEC source: 0000899243-22-034477 · doc4.xml · nonDerivative · entry 4 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 23,373,591 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| October 27, 2022 Filed Oct 28, 2022 22:49 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 204,478 | $2.71 | $553,317.47 |
DisclosureSEC source: 0000899243-22-034477 · doc4.xml · nonDerivative · entry 3 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,373,592 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| October 26, 2022 Filed Oct 28, 2022 22:49 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 189,138 | $2.90 | $549,256.75 |
DisclosureSEC source: 0000899243-22-034477 · doc4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 23,578,068 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| October 26, 2022 Filed Oct 28, 2022 22:49 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 189,138 | $2.90 | $549,256.75 |
DisclosureSEC source: 0000899243-22-034477 · doc4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,578,070 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| October 25, 2022 Filed Oct 26, 2022 21:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 187,442 | $2.64 | $495,596.65 |
DisclosureSEC source: 0000899243-22-034282 · doc4.xml · nonDerivative · entry 4 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 23,767,206 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| October 25, 2022 Filed Oct 26, 2022 21:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 187,441 | $2.64 | $495,594.00 |
DisclosureSEC source: 0000899243-22-034282 · doc4.xml · nonDerivative · entry 3 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,767,208 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| October 24, 2022 Filed Oct 26, 2022 21:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 206,504 | $2.48 | $511,510.41 |
DisclosureSEC source: 0000899243-22-034282 · doc4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 23,954,648 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| October 24, 2022 Filed Oct 26, 2022 21:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 206,503 | $2.48 | $511,507.93 |
DisclosureSEC source: 0000899243-22-034282 · doc4.xml · nonDerivative · entry 1 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,954,649 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| October 21, 2022 Filed Oct 24, 2022 21:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 201,370 | $2.44 | $491,544.17 |
DisclosureSEC source: 0000899243-22-034034 · doc4.xml · nonDerivative · entry 4 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 24,161,152 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| October 21, 2022 Filed Oct 24, 2022 21:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 201,371 | $2.44 | $491,546.61 |
DisclosureSEC source: 0000899243-22-034034 · doc4.xml · nonDerivative · entry 3 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,161,152 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
| October 20, 2022 Filed Oct 24, 2022 21:30 UTC | Ginkgo Bioworks Holdings, Inc. DNA · Entity 5530 | SaleClass A Common Stock | 196,721 | $2.47 | $485,507.43 |
DisclosureSEC source: 0000899243-22-034034 · doc4.xml · nonDerivative · entry 2 Canton Barry · CIK 0001882756 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 24,362,522 F1 · kind: Represents the number of shares sold by the Reporting Person or the Reporting Person's spouse to cover tax withholding obligations in connection with the vesting of RSUs. Sales to cover tax withholding obligations in connection with the vesting of such securities do not represent discretionary trades by the Reporting Person or the Reporting Person's spouse. The Issuer's equity incentive plans allow the Issuer to require that satisfaction of tax withholding obligations be funded by a "sell to cover" transaction. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.